Hospira Earnings Preview: Can This Streak Continue?

Hospira (NYSE:HSP) will report earnings before markets open on Wednesday, May 1st. Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. The Company’s product portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.6 to a profit $0.51. For the current year, the average estimate is a profit of $2.03, which is worse than the estimate ninety days ago.